Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.58 |
| ▸ | DPP4 | P27487 | 8/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | KRAS | P01116 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7189383 | 1.00 | PTPN1 (0.58) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7185991 | 0.91 | PTPN1 (0.56) | PTPN1DPP4CTSLCTSBCA1 | |
| SCHEMBL7185985 | 0.91 | PTPN1 (0.56) | PTPN1DPP4CTSLCTSBCA1 | |
| SCHEMBL7191601 | 0.90 | MAPT (0.51) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7185017 | 0.90 | DPP4 (0.56) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7191596 | 0.90 | MAPT (0.51) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7185020 | 0.90 | DPP4 (0.56) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7177758 | 0.88 | PTPN1 (0.58) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7177757 | 0.88 | PTPN1 (0.58) | PTPN1DPP4CTSLCTSBLMNA | |
| SCHEMBL7184180 | 0.86 | PTPN1 (0.76) | PTPN1DPP4CTSLCTSBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |
| US-5985935-A | PARASITICIDES OR BACTERICIDES | STATENS SERUMINSTITUT (DK) | 1999-11-16 | — | — | US | disclosed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | disclosed |